Ryota Iwasawa

783 total citations
7 papers, 642 citations indexed

About

Ryota Iwasawa is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ryota Iwasawa has authored 7 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Ryota Iwasawa's work include Colorectal Cancer Treatments and Studies (3 papers), Mitochondrial Function and Pathology (2 papers) and Gastric Cancer Management and Outcomes (2 papers). Ryota Iwasawa is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Mitochondrial Function and Pathology (2 papers) and Gastric Cancer Management and Outcomes (2 papers). Ryota Iwasawa collaborates with scholars based in United Kingdom, Spain and Malaysia. Ryota Iwasawa's co-authors include Evangelos Pazarentzos, Stefan Grimm, Christoph Datler, Anne‐Laure Mahul‐Mellier, Nabil Hajji, Aleksandra Dąbrowska, Mohammed K. Hankir, Sunniyat Rahman, Alan R. Boobis and José L. Venero and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Ryota Iwasawa

6 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryota Iwasawa United Kingdom	5	491	181	152	85	78	7	642
Aleck W.E. Jones United Kingdom	9	509 1.0×	183 1.0×	234 1.5×	88 1.0×	63 0.8×	9	762
Luis Carlos Tábara United Kingdom	12	467 1.0×	168 0.9×	196 1.3×	96 1.1×	87 1.1×	16	737
Ryo Yonashiro Japan	8	694 1.4×	109 0.6×	234 1.5×	101 1.2×	94 1.2×	8	841
Ai Ling Wang United States	12	603 1.2×	69 0.4×	170 1.1×	62 0.7×	70 0.9×	17	978
Danny V. Jeyaraju Canada	11	371 0.8×	91 0.5×	85 0.6×	80 0.9×	60 0.8×	25	480
Matthew Yoke Wui Ng Norway	8	377 0.8×	110 0.6×	249 1.6×	85 1.0×	44 0.6×	9	602
Karolina Szczepanowska Germany	14	586 1.2×	148 0.8×	78 0.5×	117 1.4×	123 1.6×	19	726
Joo Hyun Lim South Korea	15	595 1.2×	138 0.8×	181 1.2×	194 2.3×	52 0.7×	24	901
Elettra Sara Marini Italy	9	294 0.6×	146 0.8×	227 1.5×	76 0.9×	20 0.3×	9	471
Ricarda Richter‐Dennerlein Germany	16	1.1k 2.3×	109 0.6×	116 0.8×	86 1.0×	253 3.2×	26	1.2k

Countries citing papers authored by Ryota Iwasawa

Since Specialization

Citations

This map shows the geographic impact of Ryota Iwasawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Iwasawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Iwasawa more than expected).

Fields of papers citing papers by Ryota Iwasawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Iwasawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Iwasawa. The network helps show where Ryota Iwasawa may publish in the future.

Co-authorship network of co-authors of Ryota Iwasawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Iwasawa. A scholar is included among the top collaborators of Ryota Iwasawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Iwasawa. Ryota Iwasawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Arnold, Dirk, Andrés Cervantes, Michel Ducreux, et al.. (2025). OrigAMI-2: A randomized, phase 3 study of amivantamab vs cetuximab, both in combination with FOLFOX or FOLFIRI, as first-line treatment in left-sided RAS / BRAF wild-type metastatic colorectal cancer.. Journal of Clinical Oncology. 43(16_suppl).

Raghav, Kanwal, Eric Van Cutsem, Dirk Arnold, et al.. (2025). Amivantamab with or without chemotherapy in right-sided metastatic colorectal cancer: Updated results from OrigAMI-1, an open-label, phase 1b/2 study.. Journal of Clinical Oncology. 43(4_suppl). 197–197. 1 indexed citations

Oberstein, Paul E., Víctor Moreno, Kanwal Raghav, et al.. (2024). Amivantamab monotherapy in relapsed/refractory metastatic colorectal cancer: OrigAMI-1, an open-label, phase 1b/2 study.. Journal of Clinical Oncology. 42(3_suppl). 135–135. 4 indexed citations

Dąbrowska, Aleksandra, José L. Venero, Ryota Iwasawa, et al.. (2015). PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity. Aging. 7(9). 629–643. 99 indexed citations

Malik, Poonam, Alijan Tabarraei, Ralph H. Kehlenbach, et al.. (2012). Herpes Simplex Virus ICP27 Protein Directly Interacts with the Nuclear Pore Complex through Nup62, Inhibiting Host Nucleocytoplasmic Transport Pathways. Journal of Biological Chemistry. 287(15). 12277–12292. 45 indexed citations

Pazarentzos, Evangelos, et al.. (2011). De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF. Cell Death and Differentiation. 19(5). 891–899. 65 indexed citations

Iwasawa, Ryota, Anne‐Laure Mahul‐Mellier, Christoph Datler, Evangelos Pazarentzos, & Stefan Grimm. (2010). Fis1 and Bap31 bridge the mitochondria–ER interface to establish a platform for apoptosis induction. The EMBO Journal. 30(3). 556–568. 428 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact